stella
beta
Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients — Stella
Recruiting
Back to Triple Negative Breast Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
Taiwan
National Taiwan University Hospital, Taipei
View full record on ClinicalTrials.gov